Skip to main content
. 2020 Jul 6;128(7):077001. doi: 10.1289/EHP5184

Table 2.

Average difference (β) in marker of adiposity in offspring at 3 and 18 months of age pooled, and at respective visits for 1-unit (ng/mL) increase in maternal pregnancy serum PFAA concentration.

Compound (ng/mL) BMI SDS Ponderal index SDS Waist circumference SDS
β (95% CI) p pinta β (95% CI) p pinta β (95% CI) p pinta
PFHxS pooled 3 and 18 months
 Crudeb 0.04 (0.16, 0.25) 0.68 0.07 (0.13, 0.28) 0.48 0.01 (0.20, 0.18) 0.94
 Adjustedc 0.04 (0.16, 0.24) 0.67 0.90 0.08 (0.12, 0.29) 0.43 0.69 0.01 (0.18, 0.19) 0.95 0.62
Respective visits
 Birthd 0.19 (0.04, 0.43) 0.11 0.24 (0.01, 0.47) 0.05 0.13 (0.11, 0.36) 0.28
 3 monthse 0.05 (0.18, 0.28) 0.66 0.10 (0.14, 0.33) 0.42 0.03 (0.18, 0.25) 0.76
 18 monthse 0.04 (0.19, 0.26) 0.76 0.05 (0.18, 0.29) 0.67 0.02 (0.24, 0.20) 0.84
PFOS pooled 3 and 18 months
 Crudeb 0.01 (0.03, 0.01) 0.46 0.01 (0.03, 0.02) 0.62 0.01 (0.03, 0.004) 0.12
 Adjustedc 0.01 (0.03, 0.01) 0.53 0.84 0.004 (0.03, 0.02) 0.77 0.85 0.01 (0.03, 0.01) 0.31 0.18
Respective visits
 Birthd 0.02 (0.01, 0.04) 0.15 0.03 (0.01, 0.05) 0.02 0.001 (0.02, 0.02) 0.95
 3 monthse 0.01 (0.03, 0.02) 0.63 0.005 (0.03, 0.016) 0.63 0.02 (0.04, 0.004) 0.13
 18 monthse 0.01 (0.03, 0.02) 0.52 0.003 (0.03, 0.020) 0.78 0.001 (0.02, 0.02) 0.93
PFOA pooled 3 and 18 months
 Crudeb 0.03 (0.03, 0.08) 0.35 0.05 (0.003, 0.11) 0.06 0.01 (0.06, 0.04) 0.73
 Adjustedc 0.04 (0.01, 0.10) 0.14 0.42 0.07 (0.01, 0.13) 0.02 0.43 0.01 (0.04, 0.07) 0.62 0.06
Respective visits
 Birthd 0.02 (0.04, 0.09) 0.50 0.05 (0.01, 0.12) 0.10 0.02 (0.08, 0.05) 0.59
 3 monthse 0.03 (0.03, 0.10) 0.29 0.06 (0.004, 0.12) 0.07 0.01 (0.07, 0.05) 0.72
 18 monthse 0.06 (0.01, 0.13) 0.09 0.09 (0.02, 0.16) 0.02 0.05 (0.02, 0.12) 0.13
PFNA pooled 3 and 18 months
 Crudeb 0.13 (0.04, 0.30) 0.13 0.20 (0.03, 0.36) 0.02 0.03 (0.12, 0.18) 0.70
 Adjustedc 0.18 (0.02, 0.34) 0.03 0.74 0.24 (0.08, 0.41) <0.01 0.82 0.09 (0.06, 0.24) 0.25 0.62
Respective visits
 Birthd 0.04 (0.23, 0.15) 0.65 0.03 (0.16, 0.21) 0.79 0.10 (0.30, 0.09) 0.28
 3 monthse 0.17 (0.01, 0.35) 0.07 0.23 (0.05, 0.42) 0.01 0.07 (0.11, 0.24) 0.45
 18 monthse 0.20 (0.01, 0.39) 0.04 0.25 (0.06, 0.45) 0.01 0.12 (0.07, 0.30) 0.22
PFDA pooled 3 and 18 months
 Crudeb 0.33 (0.10, 0.76) 0.13 0.53 (0.11, 0.96) 0.02 0.03 (0.37, 0.42) 0.90
 Adjustedc 0.42 (0.01, 0.84) 0.05 0.89 0.60 (0.18, 1.02) <0.01 0.92 0.10 (0.28, 0.49) 0.60 0.97
Respective visits
 Birthd 0.08 (0.40, 0.56) 0.74 0.20 (0.27, 0.67) 0.41 0.07 (0.55, 0.41) 0.78
 3 monthse 0.41 (0.04, 0.87) 0.08 0.61 (0.14, 1.07) 0.01 0.10 (0.34, 0.54) 0.66
 18 monthse 0.38 (0.12, 0.88) 0.12 0.59 (0.07, 1.10) 0.03 0.11 (0.36, 0.57) 0.65

Note: BMI, body mass index; CI, confidence interval; PFDA, perfluorodecanoic acid; PFHxS, perfluorohexane sulfonic acid; PFNA, perfluorononanoic acid; PFOA, perfluorooctanoic acid; PFOS, perfluorooctane sulfonic acid; SDS, standard deviation scores.

a

Interaction between the compound and visit (3 months or 18 months), tested with the likelihood-ratio test.

b

Mixed modeling (n=600 for BMI SDS and ponderal index SDS, n=596 for waist circumference SDS).

c

Mixed modeling: Adjusted for maternal age, parity, prepregnancy BMI, prepregnancy BMI2, educational level, smoking, sex, visit, and adiposity marker at birth. (n=593 for BMI SDS and ponderal index SDS, n=589 for waist circumference SDS).

d

Linear regression: Adjusted for maternal age, parity, prepregnancy BMI, prepregnancy BMI2, educational level, smoking, and sex. (n=593 for BMI SDS and ponderal index SDS, n=589 for waist circumference SDS).

e

Mixed modeling: Adjusted for maternal age, parity, prepregnancy BMI, prepregnancy BMI2, educational level, smoking, sex, and adiposity marker at birth. (n=593 for BMI SDS and ponderal index SDS; n=589 for waist circumference SDS).